EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia

Adrian Martyniak iD, Zuzanna Zakrzewska, Magdalena Schab, Aleksandra Zawartka, Andrzej Wędrychowicz, Szymon Skoczeń iD, Przemysław J Tomasik iD

Microorganisms · 08.07.2023 · 11 (7) · 1775

DOI: 10.3390/microorganisms11071775 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 08.07.2023. Verfasst von Adrian Martyniak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Pediatric Institute, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia (ALL) is the most common type of leukemia in children, comprising 75–85% of cases. Aggressive treatment of leukemias includes chemotherapy and antibiotics that often disrupt the host microbiota. Additionally, the gut microbiota may play a role in the development and progression of acute leukemia. Prebiotics, probiotics, and postbiotics are considered beneficial to health. The role of prebiotics in the treatment and development of leukemia is not well understood, but inulin can be potentially used in the treatment of leukemia. Some probiotic bacteria such as Lactobacillus shows anticancer activity in in vitro studies. Additionally, Bifidobacterium spp., as a consequence of the inhibition of growth factor signaling and mitochondrial-mediated apoptosis, decrease the proliferation of cancer cells. Many bacterial metabolites have promising anticancer potential. The available research results are promising. However, more research is needed in humans, especially in the child population, to fully understand the relationship between the gut microbiota and acute leukemia.

Schlagwörter

Stichwörter der Autor:innen

SCFAanticancerfiberfolic acidgastrointestinal tractinulinlactobacillusmicrobiotapectintryptophan

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Pediatric Institute, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.
  • Department of Pediatric Oncology and Hematology, Pediatric Institute, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.
  • Department of Paediatrics, Gastroenterology and Nutrition, Pediatric Institute, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

ORCID-Profile: Adrian Martyniak, Szymon Skoczeń, Przemysław J Tomasik

Zitieren

APA

Martyniak, A., Zakrzewska, Z., Schab, M., Zawartka, A., Wędrychowicz, A., Skoczeń, S., & Tomasik, P. J. (2023). Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia. Microorganisms, 11(7), 1775. https://doi.org/10.3390/microorganisms11071775

Vancouver

Martyniak A, Zakrzewska Z, Schab M, Zawartka A, Wędrychowicz A, Skoczeń S, et al. Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia. Microorganisms. 2023;11(7):1775. doi:10.3390/microorganisms11071775

BibTeX
@article{Martyniak2023,
  author = {Martyniak, Adrian and Zakrzewska, Zuzanna and Schab, Magdalena and Zawartka, Aleksandra and Wędrychowicz, Andrzej and Skoczeń, Szymon and Tomasik, Przemysław J},
  title = {Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {7},
  pages = {1775},
  doi = {10.3390/microorganisms11071775}
}
Kostenlos starten →